Leon-Ferre RA, Perez EA, Hillman DW, Bueno C, et al. N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer. Breast Cancer Res Treat 2020 Jun 5. pii: 10.1007/s10549-020-05709.
PMID: 32504284